Global Preimplantation Genetics Diagnosis (PGD) Market Size, Status and Forecast 2020-2026

Market Analysis and Insights: Global Preimplantation Genetics Diagnosis (PGD) Market
In 2019, the global Preimplantation Genetics Diagnosis (PGD) market size was US$ 96.4 million and it is expected to reach US$ 123.1 million by the end of 2026, with a CAGR of 3.5% during 2021-2026.
Global Preimplantation Genetics Diagnosis (PGD) Scope and Market Size
Preimplantation Genetics Diagnosis (PGD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetics Diagnosis (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Preimplantation Genetics Diagnosis (PGD) market is segmented into Gender Selection, Chromosomal Abnormalities, Single Gene Disorders, HLA Typing, Aneuploidy, X-Linked Diseases, Other, etc.
Segment by Application, the Preimplantation Genetics Diagnosis (PGD) market is segmented into Hospitals, Clinics, Other, etc.
Regional and Country-level Analysis
The Preimplantation Genetics Diagnosis (PGD) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Preimplantation Genetics Diagnosis (PGD) market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Preimplantation Genetics Diagnosis (PGD) Market Share Analysis
Preimplantation Genetics Diagnosis (PGD) market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Preimplantation Genetics Diagnosis (PGD) business, the date to enter into the Preimplantation Genetics Diagnosis (PGD) market, Preimplantation Genetics Diagnosis (PGD) product introduction, recent developments, etc.
The major vendors include Abbott Laboratories, Natera, Inc, PerkinElmer, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Agilent Technologies, Quest Diagnostics Incorporated, Cooper Surgical, Beijing Genomics Institute (BGI), Genea Limited, etc.

This report focuses on the global Preimplantation Genetics Diagnosis (PGD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Preimplantation Genetics Diagnosis (PGD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Abbott Laboratories
Natera, Inc
PerkinElmer
Illumina
F. Hoffmann-La Roche
Thermo Fisher Scientific
Laboratory Corporation of America Holdings
Agilent Technologies
Quest Diagnostics Incorporated
Cooper Surgical
Beijing Genomics Institute (BGI)
Genea Limited

Market segment by Type, the product can be split into

Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
Aneuploidy
X-Linked Diseases
Other

Market segment by Application, split into

Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Preimplantation Genetics Diagnosis (PGD) status, future forecast, growth opportunity, key market and key players.
To present the Preimplantation Genetics Diagnosis (PGD) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Preimplantation Genetics Diagnosis (PGD) are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.